Streamlining data analysis of genomes and exomes in oncology clinical research

Rapid advances in genomics technologies have ushered in a new paradigm for precision medicine — especially in oncology. However, complex assays such as genomes (WGS) and exomes (WES), along with expanding biomarker knowledge and guidelines, pose challenges for labs especially with data analysis and interpretation. In this educational webinar, we overview Illumina Software solutions for trusted and streamlined oncology clinical research data analysis. Hear how DRAGEN™ secondary analysis enables accurate, comprehensive, and efficient variant calling and see the integrated path for lab tertiary analysis through research report generation using Illumina Connected Insights. Trial environments, with full support, will be available upon request following the webinar.​

Key learnings include:​

• Considerations for data analysis and data operations for somatic genomes and exomes​ ​
• DRAGEN secondary analysis capabilities to streamline high complexity, high volume variant data
• Experience a WGS variant interpretation demo, generating insights and a research report, in Illumina Connected Insights​
• Gain access to trial environments for your hands-on experience

Presenters

Rami Mehio
Vice President, Head of Software and Informatics
Illumina

Severine Catreux
Senior Director of Bioinformatics
Illumina

Sam Ng
Bioinformatics Scientist
Illumina

M-EMEA-01590​